Genome-wide association study meta-analysis of neurofilament light (NfL) levels in blood reveals novel loci related to neurodegeneration
Shahzad Ahmad,Mohammad Aslam Imtiaz,Aniket Mishra,Ruiqi Wang,Marisol Herrera-Rivero,Joshua C Bis,Myriam Fornage,Gennady Roshchupkin,Edith Hofer,Mark Logue,W T Longstreth Jr,Rui Xia,Vincent Bouteloup,Thomas Mosley,Lenore J Launer,Michael Khalil,Jens Kuhle,Robert A Rissman,Genevieve Chene,Carole Dufouil,Luc Djoussé,Michael J Lyons,Kenneth J Mukamal,William S Kremen,Carol E Franz,Reinhold Schmidt,Stephanie Debette,Monique M B Breteler,Klaus Berger,Qiong Yang,Sudha Seshadri,N Ahmad Aziz,Mohsen Ghanbari,M Arfan Ikram
DOI: https://doi.org/10.1038/s42003-024-06804-3
2024-09-09
Abstract:Neurofilament light chain (NfL) levels in circulation have been established as a sensitive biomarker of neuro-axonal damage across a range of neurodegenerative disorders. Elucidation of the genetic architecture of blood NfL levels could provide new insights into molecular mechanisms underlying neurodegenerative disorders. In this meta-analysis of genome-wide association studies (GWAS) of blood NfL levels from eleven cohorts of European ancestry, we identify two genome-wide significant loci at 16p12 (UMOD) and 17q24 (SLC39A11). We observe association of three loci at 1q43 (FMN2), 12q14, and 12q21 with blood NfL levels in the meta-analysis of African-American ancestry. In the trans-ethnic meta-analysis, we identify three additional genome-wide significant loci at 1p32 (FGGY), 6q14 (TBX18), and 4q21. In the post-GWAS analyses, we observe the association of higher NfL polygenic risk score with increased plasma levels of total-tau, Aβ-40, Aβ-42, and higher incidence of Alzheimer's disease in the Rotterdam Study. Furthermore, Mendelian randomization analysis results suggest that a lower kidney function could cause higher blood NfL levels. This study uncovers multiple genetic loci of blood NfL levels, highlighting the genes related to molecular mechanism of neurodegeneration.